Aardvark Therapeutics (AARD) Income Statement: Revenue & Earnings

Aardvark Therapeutics Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

Aardvark Therapeutics, Inc. income statement - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022
Period Ending	Dec 2024	Dec 2023	Dec 2022
Revenue & Gross Profit
Revenue	0.00	0.00	0.00
Cost of Revenue	0.00	0.00	0.00
Gross Profit	0.00	0.00	0.00
Operating Expenses
Research & Development	17.36	4.48	7.17
Selling, General & Administrative	5.31	2.17	2.70
Operating Expenses	22.67	6.65	10.87
Operating Income	-22.67	-6.65	-10.87
Other Income/Expense
Interest Income	2.41	1.42	0.12
Interest Expense	0.00	0.00	0.00
Other Income/Expense	-0.33	-1.98	-2.81
Income
Income Before Tax	-20.59	-7.21	-13.56
Income Tax Expense	0.00	0.00	0.00
Net Income	-20.59	-7.21	-13.56
Net Income - Continuous Operations	-20.59	-7.21	-13.56
Net Income - Discontinued Operations	0.00	0.00	0.00
EBITDA	-22.65	-6.65	-10.76
EBIT	-22.67	-6.65	-10.87
Depreciation & Amortization	0.02	0.00	0.11
Earnings Per Share
Basic EPS	-1.00	-1.00	-1.00
Diluted EPS	-1.00	-1.00	-1.00
Basic Shares Outstanding	21.38	12.91	9.73
Diluted Shares Outstanding	21.38	12.91	9.73